BioSpace News Archive

BioMed Realty, a leading provider of real estate solutions for the life science and technology industries, has received approval from the City to expand its flagship Emeryville Center of Innovation campus.

Economic activity in the services sector grew in March for the 10th month in a row, say the nation’s purchasing and supply executives in the latest Services ISM® Report On Business®.

Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit immunosuppressive and cancer-promoting signaling pathways, today announced the forthcoming oral presentation of preclinical data on selective adenosine A 2B receptor antagonist TT-702, at the American Association for Cancer Research (AACR) Annual Meeting

How is the Centers for Disease Control and Prevention (CDC) working to tackle the challenges we face as a country to combat COVID-19? How does CDC work with public health partners and others to take on the challenge of health equity? How can public health professionals prepare communities for what might be a new normal?

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

As a second set of eyes and hands for clinicians, VBrain maximizes radiotherapy accuracy and speeds up crucial treatment time for patients.

MDimune Inc. and Evercyte GmbH announced a strategic collaboration to develop tumor-targeted drug delivery by combining MDimune’s BioDrone® platform technology based on cell-derived vesicles (CDVs) and Evercyte’s technology to modify surface proteins to create tumor-specific binding affinity.

Cigarette smoking is a chronic health problem across the globe. There has been increased focus on the adverse economic and health effects of smoking.

Synthetic biology market has evolved on the back of surging industry interest worldwide on the profound capabilities it is said to possess, mainly by virtue of redesigning biological components and systems.

The growth of the global cervical dysplasia market can be attributed to advancements in female healthcare.